# Spyre Therapeutics, Inc.: Form 8-K, filed Aug 4, 2026

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: 8-K
- Filed: 2026-08-04
- Accepted by EDGAR: Aug 4, 2026, 20:05 ET
- Period: 2026-08-04
- Accession: 0001636282-26-000098
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000098/syre-20260804.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000163628226000098/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000163628226000098/syre-20260804.htm

Filed Aug 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001636282-26-000098. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.